Trials / Completed
CompletedNCT03232671
Role of Macrophage Migration Inhibitory Factor (MIF) in Heart Failure
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 180 (actual)
- Sponsor
- University Hospital, Essen · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Evaluating the additional value of Macrophage Migration Inhibitory factor (MIF) in cardiovascular diseases when assessed in clinical routine.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | MIF ELISA | Blood sample |
Timeline
- Start date
- 2016-03-01
- Primary completion
- 2020-04-01
- Completion
- 2020-09-01
- First posted
- 2017-07-28
- Last updated
- 2022-11-04
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT03232671. Inclusion in this directory is not an endorsement.